Moringa oleifera supplemented diet modulates nootropic-related biomolecules in the brain of STZ-induced diabetic rats treated with acarbose
Autor: | Omoyemi A. Akintemi, Tosin A. Olasehinde, Sunday I. Oyeleye, Ganiyu Oboh |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Blood Glucose Male medicine.medical_specialty Antioxidant endocrine system diseases medicine.medical_treatment Biochemistry Antioxidants Diabetes Mellitus Experimental 03 medical and health sciences Cellular and Molecular Neuroscience chemistry.chemical_compound 0302 clinical medicine Internal medicine medicine Animals Hypoglycemic Agents Rats Wistar Butyrylcholinesterase Nootropic Agents Acarbose chemistry.chemical_classification Moringa oleifera biology Glutathione peroxidase nutritional and metabolic diseases Brain Glutathione Streptozotocin Arginase 030104 developmental biology Endocrinology chemistry Catalase biology.protein Neurology (clinical) 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Metabolic brain disease. 33(2) |
ISSN: | 1573-7365 |
Popis: | There are strong correlations between diabetes mellitus and cognitive dysfunction. This study sought to investigate the modulatory effects of Moringa oleifera leaf (ML) and seed (MS) inclusive diets on biomolecules [acetylcholinesterase (AChE), butyrylcholinesterase (BChE)] angiotensin-I converting enzyme (ACE), arginase, catalase, glutathione transferase (GST) and glutathione peroxidase (GSH-Px) activities, glutathione (GSH) and nitric oxide (NO) levels] associated with cognitive function in the brain of streptozotocin (STZ)-induced diabetic rats treated with acarbose (ACA). The rats were made diabetic by intraperitoneal administration of 0.1 M sodium-citrate buffer (pH 4.5) containing STZ [60 mg/kg b.w (BW)] and fed with diets containing 2 and 4% ML/MS. Acarbose (25 mg/kg BW) was administered by gavage daily for 14 days. The animals were distributed in eleven groups of eight animals as follows: control, STZ-induced, STZ + ACA, STZ + 2% ML, STZ + ACA + 2% ML, STZ + 4% ML, STZ + ACA + 4% ML, STZ + 2% MS, STZ + ACA + 2% MS, STZ + 4% MS, STZ + ACA + 4% MS. There were marked increase in AChE, BChE, arginase, ACE and concomitant decrease in catalase, GST, GSH-Px, activities and NO levels in STZ-diabetic group compared with the control. However, there was a decrease in AChE, BChE and ACE activities and concomitant increase in the antioxidant molecules in the groups fed with supplemented diets treated with/without ACA compared with the STZ-diabetic group. These findings suggest that ML/MS supplemented diet could prevent cognitive dysfunction-induced by chronic hyperglycemia. |
Databáze: | OpenAIRE |
Externí odkaz: |